Brown Brothers Harriman & Co. Has $774,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Brown Brothers Harriman & Co. raised its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 6.4% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,184 shares of the company’s stock after buying an additional 671 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Henry Schein were worth $774,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Olstein Capital Management L.P. increased its stake in shares of Henry Schein by 17.2% in the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock worth $7,543,000 after acquiring an additional 16,000 shares during the last quarter. Private Management Group Inc. increased its position in Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock worth $24,256,000 after purchasing an additional 18,882 shares during the last quarter. Equitable Trust Co. purchased a new stake in shares of Henry Schein during the 4th quarter worth about $417,000. Savant Capital LLC raised its stake in shares of Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock worth $322,000 after purchasing an additional 1,420 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company’s stock valued at $1,113,000 after buying an additional 3,650 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research firms recently commented on HSIC. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. UBS Group cut their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, February 26th. Jefferies Financial Group lifted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and a consensus target price of $81.10.

Henry Schein Trading Down 1.1 %

Henry Schein stock opened at $68.62 on Monday. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market capitalization of $8.52 billion, a PE ratio of 28.24, a PEG ratio of 2.13 and a beta of 0.90. The business’s 50-day simple moving average is $74.62 and its 200-day simple moving average is $72.68.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the firm earned $0.66 earnings per share. The business’s quarterly revenue was up 5.8% on a year-over-year basis. Equities research analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.